Publication | Closed Access

Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countries

ThrombosisVenous ThrombosisCardiovascular DiseaseNon-valvular Atrial FibrillationPatient SafetyCardiovascular PharmacologyOutcomes ResearchPharmacotherapyCoagulopathyMedicineAnticoagulantCardiologyEmergency MedicineAnesthesiology